Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases

July 19, 2018

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

FDA lifts clinical hold on Invossa trials

July 9, 2018

Bayer initiates first-in-human study with BAY-1830839

July 9, 2018

Neovacs reports phase IIb results for IFN-alpha kinoid in moderate to severe lupus

July 3, 2018

From Adam's rib to Miss Piggy's jaw

July 3, 2018

European Commission approves Xeljanz for active psoriatic arthritis

June 29, 2018

Medivir reports promising topline results from phase IIa extension study of MIV-711

June 28, 2018

Servier and Galapagos initiate phase II trial with S-201086 in osteoarthritis

June 27, 2018

AZD-9567 shows better therapeutic ratio than prednisolone in vivo and in clinical setting

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...